National Acalabrutinib Observational Study

Clinical trial NCT05437250 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05437250
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia

Start date: 2022-09-13
Primary completion: 2026-11-15
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.